Sunbit UV Measuring Device to Track Sun Behavior

An Observational Single Center Pilot Study Using a Wearable UV Sensor (Sunbit) Measuring UV Exposure of Patients at High Risk for Skin Cancer - SUNBIT Study

Status

Terminated

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02221843

Enrollment

Registered

2014-08-20

Start date

2014-08-31

Completion date

2016-03-31

Last updated

2016-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Immunosuppression, Skin Neoplasms

Keywords

sun behavior, immunosuppression, skin neoplasms, sunbit, uv sensor, uv dosimeter, solar radiation, uv exposition, uv index

Brief summary

Sunbit is a new wearable UV dosimeter to measure solar radiation in real time. The purpose of this study is to track sun behavior of patients at high risk for skin cancer, to investigate the feasibility of this prototype in daily life and to investigate the technical accuracy of the Sunbit.

Detailed description

A total of 20 patients will be included to wear the Sunbit system during the time of 4 weeks. After this 4 weeks Sunbit will be recollected and data in the form of UV Indices will be extracted and analyzed. Patients will be recruited in the Department of Dermatology of the University Hospital Zürich. The target population comprises patients with a high risk of melanoma and non-melanoma skin cancer, thus especially patients with an immunosuppressive therapy due to organ transplantation.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

50 Years to No maximum

Healthy volunteers

Inclusion criteria

* Age ≥ 18 years * History of skin cancer (melanoma or NMSC) or patients with high risk of skin cancer (e.g. immunosuppressive therapy) * Oral and written informed consent

Exclusion criteria

* Any medical condition that renders the patient bedridden for the duration of 2 weeks

Design outcomes

Primary

Measure	Time frame	Description
number of days wearing the device	after 4 weeks wearing the device	patient compliance

Secondary

Measure	Time frame	Description
difference between measured UV Indices and reference values	after 4 weeks wearing the device	technical accuracy of the device

Other

Measure	Time frame	Description
difference between the individual UV Indices	after 4 weeks wearing the device	sun behavior

Countries

Switzerland

Outcome results